Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative therapies function by mimicking the natural actions of GLP-1, a hormone secreted by the https://matteostug934969.blogspothub.com/37887474/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes